Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
MaxCyte Share News (MXCT)
MXCT Share
Price
MXCT Share
News
MXCT Share
Chat
MXCT Share
Trades63
MXCT
Live RNS
MXCT Share
Charts
MXCT Broker
Ratings
MXCT Directors
Deals
MXCT Financial
Diary
MXCT
Fundamentals
MXCT Short
Positions
MXCT
Media
MXCT Company
Research
MXCT Company
Timeline
- There is currently no data for MXCT
MaxCyte News
LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
MaxCyte reports strong fourth quarter as full-year revenues fall
(Sharecast News) - Cell engineering technology specialist MaxCyte reported total fourth quarter revenue of $15.7m on Wednesday, up 26% on the same per...
IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%
MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing "next-generation cell therapeutics" - Net loss w...
EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit
(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
MaxCyte flags lower 2023 revenue, flat 2024 growth
(Sharecast News) - Cell engineering technology specialist MaxCyte said in an update on Tuesday that it expected total 2023 revenue of between $41.1m a...
Follow the stocks
